Table 2.
Baseline patient characteristics
Rimegepant/rimegepant OLE (n = 348) | Placebo/rimegepant OLE (n = 347) | Total (n = 695) | |
---|---|---|---|
Age, years | 41.4 (13.0) | 41.2 (13.3) | 41.3 (13.1) |
Sex | |||
Women | 282 (81%) | 295 (85%) | 577 (83%) |
Men | 66 (19%) | 52 (15%) | 118 (17%) |
History of chronic migraine | |||
Yes | 74 (21%) | 89 (26%) | 163 (23%) |
No | 274 (79%) | 258 (74%) | 532 (77%) |
Primary migraine type | |||
Without aura | 185 (53%) | 193 (56%) | 378 (54%) |
With aura | 163 (47%) | 154 (44%) | 317 (46%) |
Data are mean (SD) or n (%)
OLE open-label extension